Medtronic said it held its Annual General Meeting on October 16, 2025 and that 1,109,198,321 of 1,282,616,011 ordinary shares entitled to vote as of the record date August 22, 2025 were present, either in person or by proxy, thereby constituting a quorum.

1. 01

   Medtronic said it held its Annual General Meeting on October 16, 2025 and that 1,109,198,321 of 1,282,616,011 ordinary shares entitled to vote as of the record date August 22, 2025 were present, either in person or by proxy, thereby constituting a quorum.

2. 02

   The company said shareholders elected, by separate resolutions, each of 12 director nominees to hold office until the 2026 Annual General Meeting and until his or her successor is elected. Craig Arnold received 860,168,749 votes for and 129,336,374 votes against.

3. 03

   Medtronic said the appointment of PricewaterhouseCoopers LLP as the company's independent auditor for fiscal year 2026 was approved in a non-binding vote with 1,006,339,555 votes for and 101,786,497 votes against. The advisory vote on named executive officer compensation received 925,151,188 votes for and 64,820,280 votes against.

4. 04

   The company said amendments to Article 177 (988,783,308 votes for) and to the advance notice provisions (984,572,748 votes for) were approved at the Annual General Meeting and became effective on October 16, 2025.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.